On the evening of February 10, it was announced that the company recently received the reply on Approving the public issuance of convertible corporate bonds issued by the China Securities Regulatory Commission (hereinafter referred to as the "CSRC"), which approved the company to issue convertible corporate bonds with a total face value of 3 billion yuan to the public for a period of 6 years. The reply shall be valid within 12 months from the date of approval of issuance.
Sichuan Kelun Pharmaceutical Co.Ltd(002422) according to the issuance plan of publicly issued convertible corporate bonds issued on June 18, 2021, the net funds raised after deducting the issuance expenses are intended to be used for the company's innovative preparation production line and supporting construction projects, large infusion and small water injection industrial structure upgrading construction projects, NDDs and anti-tumor preparation industrialization construction projects Digital construction projects and supplementary working capital projects.
